Credit Agricole’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $1.26M | Sell |
17,135
-1,249
| -7% | -$91.8K | ﹤0.01% | 753 |
|
|
2024
Q4 | $1.2M | Buy |
18,384
+2,955
| +19% | +$194K | ﹤0.01% | 786 |
|
|
2024
Q3 | $1.2M | Buy |
15,429
+11,660
| +309% | +$908K | 0.01% | 651 |
|
|
2024
Q2 | $294K | Hold |
3,769
| – | – | ﹤0.01% | 818 |
|
|
2024
Q1 | $258K | Buy |
3,769
+769
| +26% | +$52.6K | ﹤0.01% | 629 |
|
|
2023
Q4 | $202K | Sell |
3,000
-1,000
| -25% | -$67.4K | ﹤0.01% | 613 |
|
|
2023
Q3 | $271K | Buy |
4,000
+1,000
| +33% | +$67.7K | ﹤0.01% | 433 |
|
|
2023
Q2 | $215K | Hold |
3,000
| – | – | ﹤0.01% | 334 |
|
|
2023
Q1 | $208K | Sell |
3,000
-1,000
| -25% | -$69.4K | ﹤0.01% | 315 |
|
|
2022
Q4 | $271K | Hold |
4,000
| – | – | 0.01% | 305 |
|
|
2022
Q3 | $220K | Hold |
4,000
| – | – | ﹤0.01% | 311 |
|
|
2022
Q2 | $264K | Hold |
4,000
| – | – | 0.01% | 296 |
|
|
2022
Q1 | $265K | Hold |
4,000
| – | – | ﹤0.01% | 319 |
|
|
2021
Q4 | $233K | Sell |
4,000
-1,530
| -28% | -$89.1K | ﹤0.01% | 327 |
|
|
2021
Q3 | $332K | Buy |
5,530
+1,530
| +38% | +$91.9K | 0.01% | 277 |
|
|
2021
Q2 | $240K | Sell |
4,000
-200
| -5% | -$12K | ﹤0.01% | 282 |
|
|
2021
Q1 | $209K | Sell |
4,200
-2,370
| -36% | -$118K | 0.01% | 285 |
|
|
2020
Q4 | $328K | Buy |
+6,570
| New | +$328K | 0.01% | 239 |
|
|
2017
Q4 | – | Sell |
-4,000
| Closed | -$136K | – | 432 |
|
|
2017
Q3 | $136K | Hold |
4,000
| – | – | ﹤0.01% | 1327 |
|
|
2017
Q2 | $136K | Buy |
4,000
+2,000
| +100% | +$68K | ﹤0.01% | 1335 |
|
|
2017
Q1 | $62K | Hold |
2,000
| – | – | ﹤0.01% | 1573 |
|
|
2016
Q4 | $55K | Hold |
2,000
| – | – | ﹤0.01% | 1404 |
|
|
2016
Q3 | $66K | Buy |
+2,000
| New | +$66K | ﹤0.01% | 1465 |
|
|
2015
Q1 | – | Sell |
-2,960
| Closed | -$101K | – | 1461 |
|
|
2014
Q4 | $101K | Sell |
2,960
-6,512
| -69% | -$222K | ﹤0.01% | 1447 |
|
|
2014
Q3 | $339K | Buy |
9,472
+6,512
| +220% | +$233K | ﹤0.01% | 1271 |
|
|
2014
Q2 | $110K | Buy |
2,960
+608
| +26% | +$22.6K | ﹤0.01% | 1438 |
|
|
2014
Q1 | $76K | Buy |
+2,352
| New | +$76K | ﹤0.01% | 1376 |
|